65 results
COVID-19: ICU Guidelines for the Non-Intensivist
Infection Control
Risk Factors for Severe Disease
Initial Laboratory Workup
COVID-19 Specific Medications
Respiratory
Cardiac
Hematologic
Neuro/Sedation

#COVID19 #ICU
COVID-19: ICU Guidelines ... Non-Intensivist Infection ... Control Risk Factors ... Sedation #COVID19 #ICU ... #criticalcare #
Pulmonary Embolism Treatment
Systemic Thrombolysis
 - Exclude contraindications.
 - Indications:
   - Massive PE (definite indication)
submassive PE (risk ... 50mg IV) - 2% risk ... of ICH and 6% risk ... who are higher risk ... AcutePE #Management #CriticalCare
Central Venous Catheter site selection - Clinical Decision Aid
IJ vs Subclavian vs Supraclavicular vs Femoral by
Femoral by ease and risk ... of infection, DVT ... #Management #CriticalCare ... Locations #Sites #Infections
Clostridium Dificile Risk by Antibiotic Class

Pooled and study-specific risk estimates of community-associated CDI risk by antibiotic
Clostridium Dificile Risk ... study-specific risk ... #CDifficile #Infection ... #Association #Pharmacology ... #Class #Risk #Clindamycin
Pulmonary Embolism - Risk Stratification and Prognostication based on scores and clinical features

 • Bova score
Pulmonary Embolism ... - Risk Stratification ... @nickmmark #Pulmonary ... #Embolism #Risk ... stratification #criticalcare
ANTIBIOTIC SUSCEPTIBILITIES IN INTENSIVE CARE

Antibiotic spectra made simple(r). Version 2, now updated with new bugs &
Susceptibilities #ICU ... #CriticalCare ... #Overview #Pharmacology ... Comprehensive Review of Infectious
Stress Ulcer Prophylaxis

Stress ulcerations are common in ICU patients and may lead to hemorrhage if not
are common in ICU ... Pathophysiology • Risk ... #Prophylaxis #criticalcare ... #pharmacology #
Post-Intensive Care Syndrome (PICS)
Symptoms of PICS:
 - Physical Domain: Generalized weakness, Fatigue, Difficulty walking
 - Cognitive
Depression COMMON RISK ... FACTORS - ICU ... screening (CAM-ICU ... diagnosis #management #criticalcare ... #icu
Tranexamic Acid - Indications and Pharmacology
Pharmacokinetics:
 • MOA: Inhibits plasminogen activation to plasmin & inhibits fibrinolysis
Indications and Pharmacology ... , Post-partum, ICH ... Hypotension with rapid injection ... fatigue; Increases risk ... #Indications #Pharmacology
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors - Pharmacology ... Jardiance) - Best risk ... mortality in high risk ... hypovolemia) • GU infections ... Canagliflozin ↑ risk